Free Webinar from UCSF on Updates fro... - SHARE Metastatic ...

SHARE Metastatic Breast Cancer

6,770 members8,366 posts

Free Webinar from UCSF on Updates from the San Antonio Breast Cancer Symposium on January 12th 6 pm Pacific Time

Sparky95 profile image
2 Replies

Wed 1/12/22 ZOOM WEBINAR INFORMATION:

"Updates from the San Antonio Breast Cancer Symposium"

-=-=-=-=-

When: January 12, 2022 06:00 PM Pacific Time (US and Canada)

Topic: UCSF Bay Area Breast Cancer Forum

Join from a PC, Mac, iPad, iPhone or Android device:

Please click this URL to join. ucsf.zoom.us/j/98005938120?...

Passcode: BABCF

Or One tap mobile:

+12133388477,,98005938120#,,,,*675097# US (Los Angeles)

+16692192599,,98005938120#,,,,*675097# US (San Jose)

Written by
Sparky95 profile image
Sparky95
To view profiles and participate in discussions please or .
2 Replies
RLN-overcomer profile image
RLN-overcomer

Thank GOD I checked my e-mails which I don't do everyday. I wish we could have been emailed days before the Zoom meeting, but I will attend Thanks Happy New Year

LadyKatarina profile image
LadyKatarina

Hi Sparky--Is there any way to view this now that the date has passed?

Not what you're looking for?

You may also like...

Webinar: Report Back From ASCO on Metastatic Breast Cancer with Dr. Mark Robson

On Monday, August 6th at 1:30 pm, join Dr. Mark Robson the Chief of Breast Medicine Service at...

BCS or Mastectomy

My wife is under going Chemo for her breast cancer and surgery is to follow after Chemo 4AC + 12...

The latest information and updates about ErSO are posted on Facebook. Join the group “ErSO activism for breast cancer”

I and some members of our community joined this group. If you would like to have the current...

SABCS 2020 Recap - Exciting New Therapies!

As many are aware, the San Antonio Breast Cancer Symposium (SABCS) 2020 was held virtually this...

Trastuzumab Deruxtecan Extends Survival Over Chemotherapy for Patients With HER2-Positive Metastatic Breast Cancer

Trastuzumab deruxtecan (T-DXd) was associated with higher response rates and longer survival than...